SII to acquire 20 per cent stake in IntegriMedical : compare

Vaccines manufacturer Serum Institute of India (SII) on Friday said it is acquiring 20 per cent stake in IntegriMedical, to advance needle-free injection system technology.

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using

Related Keywords

United States , India , Australia , Sarvesh Mutha , Adar Poonawalla , Serum Institute Of India , Device Single Audit Program , Central Drugs Standard Control Organisation , Serum Institute , Injection System , Medical Device Single Audit Program , Injections System , Medical Managing Director Sarvesh Mutha ,